108 related articles for article (PubMed ID: 11755024)
1. Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.
Dudas B; Cornelli U; Lee JM; Hejna MJ; Walzer M; Lorens SA; Mervis RF; Fareed J; Hanin I
Neurobiol Aging; 2002; 23(1):97-104. PubMed ID: 11755024
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.
Rose M; Dudas B; Cornelli U; Hanin I
Neurobiol Aging; 2003; 24(3):481-90. PubMed ID: 12600723
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Rose M; Dudas B; Cornelli U; Hanin I
Brain Res; 2004 Jul; 1015(1-2):96-102. PubMed ID: 15223371
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology.
Walzer M; Lorens S; Hejna M; Fareed J; Hanin I; Cornelli U; Lee JM
Eur J Pharmacol; 2002 Jun; 445(3):211-20. PubMed ID: 12079686
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Dudas B; Rose M; Cornelli U; Hanin I
Brain Res; 2005 Feb; 1033(1):34-40. PubMed ID: 15680337
[TBL] [Abstract][Full Text] [Related]
7. Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects.
Sigurdsson EM; Lee JM; Dong XW; Hejna MJ; Lorens SA
Neurobiol Aging; 1997; 18(6):591-608. PubMed ID: 9461057
[TBL] [Abstract][Full Text] [Related]
8. The recombinant C-terminal fragment of tetanus toxin protects against cholinotoxicity by intraseptal injection of β-amyloid peptide (25-35) in rats.
Patricio-Martínez A; Mendieta L; Martínez I; Aguilera J; Limón ID
Neuroscience; 2016 Feb; 315():18-30. PubMed ID: 26687435
[TBL] [Abstract][Full Text] [Related]
9. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide.
Nakamura S; Murayama N; Noshita T; Annoura H; Ohno T
Brain Res; 2001 Sep; 912(2):128-36. PubMed ID: 11532428
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression.
Chambers CB; Sigurdsson EM; Hejna MJ; Lorens SA; Lee JM; Muma NA
Exp Neurol; 2000 Mar; 162(1):158-70. PubMed ID: 10716896
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
12. Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer's Disease.
Kim HJ; Shin EJ; Lee BH; Choi SH; Jung SW; Cho IH; Hwang SH; Kim JY; Han JS; Chung C; Jang CG; Rhim H; Kim HC; Nah SY
Mol Cells; 2015 Sep; 38(9):796-805. PubMed ID: 26255830
[TBL] [Abstract][Full Text] [Related]
13. Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats.
Sigurdsson EM; Lorens SA; Hejna MJ; Dong XW; Lee JM
Neurobiol Aging; 1996; 17(6):893-901. PubMed ID: 9363801
[TBL] [Abstract][Full Text] [Related]
14. Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells.
Zeng KW; Ko H; Yang HO; Wang XM
Neuropharmacology; 2010 Nov; 59(6):542-50. PubMed ID: 20708632
[TBL] [Abstract][Full Text] [Related]
15. beta-Amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: behavioral, neurochemical and histological effects.
Sigurdsson EM; Hejna MJ; Lee JM; Lorens SA
Behav Brain Res; 1995 Dec; 72(1-2):141-56. PubMed ID: 8788867
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.
Kar S; Issa AM; Seto D; Auld DS; Collier B; Quirion R
J Neurochem; 1998 May; 70(5):2179-87. PubMed ID: 9572306
[TBL] [Abstract][Full Text] [Related]
17. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Dudas B; Hanin I; Rose M; Wülfert E
Neurobiol Dis; 2004 Mar; 15(2):262-8. PubMed ID: 15006696
[TBL] [Abstract][Full Text] [Related]
18. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
19. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation.
Park SH; Kim JH; Bae SS; Hong KW; Lee DS; Leem JY; Choi BT; Shin HK
Biochem Biophys Res Commun; 2011 May; 408(4):602-8. PubMed ID: 21530492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
